Elizabeth Alcamo, PhD
Vice President, Corporate Strategy and Business Operations
Elizabeth (Liz) Alcamo is an experienced corporate strategy professional who has spent the past four years working in gene therapy companies focused on bringing AAV-based therapeutics to the clinic. Liz is former Senior Director, Corporate Development and IP at 4D Molecular Therapeutics. Prior to that, she was Director of Pipeline Strategy and IP Lead, Avalanche Biotechnologies (now Adverum) and Patent Agent, Bozicevic, Field and Francis LLP.
Liz received her B.S. in Biology from Williams College and her Ph.D. in immunology from MIT and completed a post-doctoral fellowship in neurobiology at Stanford University.